|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
o Affibody AB, of Stockholm, Sweden, and Agilent Technologies Inc., of Palo Alto, Calif., formed an agreement to develop advanced protein sample preparation solutions for human biomarker discovery. Affibody will design and develop engineered Affibody ligands for specific protein targets designated by Agilent, which will use them to expand its line of proteomic sample preparation products. At the end of the development phase, Affibody will supply Agilent with production quantities of the materials. Also, Agilent, which announced last week the divestiture of its Semiconductor Products Group and the intent to spin off the System-on-a-Chip business, clarified that the sale ...
Related newspaper, magazine, and journal articles:
|
|
Article: Semiconductor products developer Microsemi posts ...
Bulletin (Bend, OR);
January 26, 2007 ;
700+ words
... ... Bend operation is heavily involved in developing advanced semiconductor products for the defense sector. Microsemi reported net income of ... and analyst with investment firm Needham & Co. in New York, agreed with Peterson's assessment. "It looks like ...
|
|